Observation time, overall incidence rates and time-variant oral glucocorticoids dose–related incidence rates of hypertension
| Characteristic | Study population n = 71 642 |
|---|---|
| Total person-years of follow-up | 532 994 |
| Total incident cases, n (%) | 24 896 (34.8) |
| Time at risk per patient, median years (P25–P75) | 6.5 (2.7–11.8) |
| Incidence rates per 1000 person-years (95% CI) | |
| Overall | 46.7 (46.0–47.3) |
| Daily dose, mg | |
| Nonuse | 46.1 (45.5–46.7) |
| > 0–4.9 | 53.6 (49.5–57.9) |
| 5.0–7.4 | 52.8 (48.5–57.5) |
| ≥ 7.5 | 50.7 (47.8–53.8) |
| Cumulative dose, mg* | |
| Nonuse | 44.4 (43.7–45.4) |
| > 0–959.9 | 45.3 (43.5–47.2) |
| 960–3054.9 | 49.3 (46.9–51.8) |
| ≥ 3055 | 55.6 (54.0–57.2) |
Note: CI = confidence interval, P25 = 25th centile, P75 = 75th centile.
↵* Time-variant cumulative dose since 1 year before study entry.